Sign In
Buy LLY
$1,169.86
+53.75 (+4.82%)
At Close: Aug 05, 2026
Eli Lilly Stock Value Tops $1 Trillion. Learn Why And If To Buy $LLY
11:10am, Saturday, 22'nd Nov 2025
Eli Lilly stock has risen 36% this year to reach a $1 trillion market capitalization – the first health-care company to reach this milestone, according to CNBC.
Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds
05:44am, Saturday, 22'nd Nov 2025
Eli Lilly has surged 47% since my last article, exceeding my previous $800 price target and reaching all-time highs near $1,030. LLY's leadership in the obesity treatment market continues to drive top
Bahl & Gaynor Inc. Reduces Stock Holdings in Eli Lilly and Company $LLY
05:20am, Saturday, 22'nd Nov 2025
Bahl and Gaynor Inc. trimmed its stake in Eli Lilly and Company (NYSE: LLY) by 1.5% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commis
Eli Lilly and Company $LLY Shares Sold by Artisan Partners Limited Partnership
04:42am, Saturday, 22'nd Nov 2025
Artisan Partners Limited Partnership decreased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 22.4% during the second quarter, according to its most recent 13F filing with the Securities
When Investors Panic, I Buy Eli Lilly
04:14am, Saturday, 22'nd Nov 2025
Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and
Market Today: Nvidia whipsaws, WBD draws bids, Lilly tops $1T
05:34pm, Friday, 21'st Nov 2025
Stock News AI-led whipsaws hit Wall Street: Nvidia (NVDA) reversed from a post-earnings pop to a sharp drop, fueling a turbulent week in which major indexes fin
The Score: Nvidia, Constellation, Eli Lilly, Gap and More Stocks That Defined the Week
05:16pm, Friday, 21'st Nov 2025
The Score is a weekly review of the biggest stock moves and the news that drove them.
LLY Becomes Biggest Healthcare Company: Analyzing Stock's Stunning Rally
04:00pm, Friday, 21'st Nov 2025
Eli Lilly (LLY) became the 10th U.S. company to tap $1 trillion in market cap and has outperformed most of its peers, particularly its biggest rival, Novo Nordisk (NVO). Rick Ducat shows just how mass
Eli Lilly becomes first health-care company to hit $1 trillion
03:11pm, Friday, 21'st Nov 2025
Silicon Valley's giants crowd the list of the world's most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of one trillion dollars on Frid
3 Weight-Loss Drug Stocks To Consider For 2026
01:58pm, Friday, 21'st Nov 2025
The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it's set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanl
Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
11:52am, Friday, 21'st Nov 2025
Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Eli Lilly reaches $1 trillion market value for first time
11:32am, Friday, 21'st Nov 2025
Eli Lilly (LLY, Financials) became the first health-care business to enter a club usually only open to technology titans when its market value hit $1 trillion f
Eli Lilly's Market Cap Breaks $1 Trillion After Climbing $400 Billion in 3 Months
11:29am, Friday, 21'st Nov 2025
It's the only drug company ever to have a $1 trillion capitalization value; the other U.S. companies are tech giants and Berkshire Hathaway.
Eli Lilly first healthcare company to hit $1T market capitalization
11:19am, Friday, 21'st Nov 2025
Eli Lilly and Co (NYSE:LLY) briefly reached a market capitalization of $1 trillion during trading on Friday, making it the first healthcare company to achieve this milestone. Shares of the Indianapoli
Zepbound maker Eli Lilly hits $1T market cap — becoming first drug company to reach milestone
11:14am, Friday, 21'st Nov 2025
A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.
